nateglinide 60 MG Oral Tablet

1 INDICATIONS AND USAGE Nateglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use: Nateglinide should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Nateglinide is a glinide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use : Not for treating type 1 diabetes mellitus or diabetes ketoacidosis ( 1 )

Actavis Pharma, Inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] off label use` `[3] fatigue` `[4] pain` `[5] rash` `[6] alopecia` `[7] abdominal discomfort` `[8] headache` `[9] nausea` `[10] condition aggravated`

4 years ago

ROUND PINK WPI 3354

16 HOW SUPPLIED/STORAGE AND HANDLING How Supplied

NATEGLINIDE tablets, USP 60 mg pink, circular, biconvex tablet with “ WPI ” debossed on one side and “ 3354 ” on the other. Bottles of 100 NDC 0591-3354-01 120 mg pink, capsule-shaped, biconvex tablet with “ WPI ” debossed on one side and “ 3355 ” on the other. Bottles of 100 NDC 0591-3355-01 Storage and Handling Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight container, USP.

More pills like ROUND WPI 3354

Related Pills

nateglinide 120 MG Oral Tablet

Actavis Pharma, Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site